# Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

> **NCT00410631** · PHASE3 · UNKNOWN · sponsor: **German Society for Pediatric Oncology and Hematology GPOH gGmbH** · enrollment: 642 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide phosphate
- **DRUG:** ifosfamide
- **DRUG:** isotretinoin
- **DRUG:** melphalan
- **DRUG:** topotecan hydrochloride
- **DRUG:** vincristine sulfate
- **DRUG:** vindesine
- **PROCEDURE:** autologous hematopoietic stem cell transplantation
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** iobenguane I 131
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00410631
- **Lead sponsor:** German Society for Pediatric Oncology and Hematology GPOH gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-10
- **Primary completion:** 2010-12
- **Final completion:** —
- **Target enrollment:** 642 (ESTIMATED)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410631, "Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00410631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*